Sfoglia per Autore
High rate of hepatitis B viral breakthrough in elderly non-Hodgkin lymphomas patients treated with Rituximab based chemotherapy
2016-01-01 Castelli, R.; Ferraris, L.; Pantaleo, G.; Lambertenghi Deliliers, G.; Cicardi, M.
The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity
2016-01-01 Wu, Ma; Castelli, R
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency
2016-01-01 Castelli, R.; Wu, M. A.; Arquati, M.; Zanichelli, A.; Suffritti, C.; Rossi, D.; Cicardi, M.
Management of anaemia in onco-haematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study
2017-01-01 Giovanni, Rosti; Mario, Petrini; Alberto, Bosi; Piero, Galieni; Daniele, Bernardi; Gianfranco, Giglio; Laura, Dorotea; Brunangelo, Falini; Elvira, Scelzi; Enzo, Veltri; Castelli, R; Chiara, Longagnani; Tommaso, Raggi; Federico Simonetti on BEHALF of “ANEMONE” STUDY, Group
Personalized treatment strategies for elderly patients with myelodysplastic syndromes
2017-01-01 Castelli, R.; Bergamaschini, L. C.; Schiavon, R.; Lambertenghi Deliliers, G.
Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study
2017-01-01 Castelli, R; Sciara, S; Lambertenghi Deliliers, G; Pantaleo, G
Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency : clinical and molecular characterization
2018-01-01 Sbattella, M.; Zanichelli, A.; Ghia, P.; Gattei, V.; Suffritti, C.; Teatini, T.; Cicardi, M.; Castelli, R.
Managment of anemia in low risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents
2018-01-01 Castelli, R; Schiavon, R; Rossi, V; Lambertenghi Deliliers, G
The impact of anaemia, transfusion dependency, commorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes
2018-01-01 Castelli, R; Schiavon, R; Lambertenghi Deliliers, G.
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation
2018-01-01 Castelli, Roberto; Gallipoli, Paolo; Paolo;, Schiavon; Teatini, Thomas; Deliliers, Giorgio Lambertenghi; Giorgio Lambertenghi;, Bergamaschini
Clinical Characteristics and treatment outcome of an 86-year old patient with acute myeloid leukemia with acute promyelocytic - like morphology and uncommon RARA fusion variant
2018-01-01 Castelli, R; Rossi, V della Porta MG Schiavon R Barchiesi M Cicconi L Lo Coco F
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas
2018-01-01 Castelli, Roberto; Roberto*;, Bergamaschini; Deliliers, Giorgio Lambertenghi
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical praticeguidelineupdate
2019-01-01 Bohlius, J; Bohlke, K; Castelli, R; Djulbegovic, B; Lustberg, Mb; Martino, M; Mountzios, G; Peswani, N; Porter, L; Tanaka, Tn; Trifirò, G; Yang, H; Lazo-Langner, A.
Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation
2019-01-01 Castelli, Roberto; Gallipoli, Paolo; Schiavon, Riccardo; Teatini, Thomas; Deliliers, Giorgio Lambertenghi; Bergamaschini, Luigi
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update
2019-01-01 Bohlius, J; Bohlke, K; Castelli, R; Djulbegovic, B; Lustberg, Mb; Martino, M; Mountzios, G; Peswani, N; Porter, L; Tanaka, Tn; Trifirò, G; Yang, H; Lazo-Langner, A.
Ibrutinib related bleeding complications in elderly patients with lymphoprolipherative disease
2019-01-01 Castelli, R; Schiavon, R; Preti, C; Lambertenghi Deliliers, G
Complement Activation in Patients With Immune Thrombocytopenic Purpura According to Phases of Disease Course
2020-01-01 Castelli, R; LAMBERTENGHI DELILIERS, G; Gidaro, A; Cicardi, M; Bergamaschini, L.
Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study
2020-01-01 Castelli, R; Bergamaschini, L; Teatini, T; Cilumbriellol, ; Schiavon, R; Gallipoli, P; LAMBERTENGHI DELILIERS, G.
Hiv-Related Lymphoprolipherative Diseases In The Era Of Combination Antiretroviral Therapy
2020-01-01 Castelli, R; Schiavon, R; Preti, C; L, Ferraris
Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection
2020-01-01 Castelli, R; Gidaro, A
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile